PMID: 26321196Sep 1, 2015Paper

Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines

Current Drug Metabolism
Derek W EdwardsonAmadeo M Parissenti

Abstract

Many clinical studies involving anti-tumor agents neglect to consider how these agents are metabolized within the host and whether the creation of specific metabolites alters drug therapeutic properties or toxic side effects. However, this is not the case for the anthracycline class of chemotherapy drugs. This review describes the various enzymes involved in the one electron (semi-quinone) or two electron (hydroxylation) reduction of anthracyclines, or in their reductive deglycosidation into deoxyaglycones. The effects of these reductions on drug antitumor efficacy and toxic side effects are also discussed. Current evidence suggests that the one electron reduction of anthracyclines augments both their tumor toxicity and their toxicity towards the host, in particular their cardiotoxicity. In contrast, the two electron reduction (hydroxylation) of anthracyclines strongly reduces their ability to kill tumor cells, while augmenting cardiotoxicity through their accumulation within cardiomyocytes and their direct effects on excitation/contraction coupling within the myocytes. The reductive deglycosidation of anthracyclines appears to inactivate the drug and only occurs under rare, anaerobic conditions. This knowledge has resulted in ...Continue Reading

Citations

Feb 23, 2018·Antioxidants·Peter Brenneisen, Andreas S Reichert
Aug 24, 2018·Journal of Adolescent and Young Adult Oncology·Claire BergerHugues Patural
Dec 13, 2017·International Journal of Molecular Sciences·Simona SeriniGabriella Calviello
Feb 6, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xiangbin DuYingqi Li
Feb 23, 2020·Biochemistry. Biokhimii︠a︡·G A BelitskiyM G Yakubovskaya
Jul 28, 2020·Journal of Toxicology·Olufunke Esan OlorundareHasan Mukhtar
Aug 9, 2020·FEBS Letters·Mushtaq M KhazeemCaroline A Austin
Aug 17, 2020·Current Opinion in Pediatrics·Erika N ScottColin J D Ross
Jun 14, 2020·International Journal of Molecular Sciences·Aleksandra KaczorowskaMarta Kopaczyńska
Apr 22, 2020·ChemMedChem·Maristela B Martins-Teixeira, Ivone Carvalho
Apr 26, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Soňa PecháčkováLibor Macurek
Jun 11, 2020·Breast Cancer Research : BCR·Li YinShi-Cang Yu
Sep 26, 2020·Frontiers in Cell and Developmental Biology·Amanda J EakinCristina M Branco
Oct 30, 2020·British Journal of Clinical Pharmacology·Benedetta C Sallustio, Alan V Boddy
May 22, 2019·Seminars in Cell & Developmental Biology·Tânia CapelôaPierre Sonveaux
Jul 7, 2020·Journal of Pharmacological and Toxicological Methods·Mahnaz MaddahAlexandre J S Ribeiro
Mar 7, 2021·International Journal of Molecular Sciences·Encarnación FusterMiguel A Sogorb
Mar 30, 2021·The Breast : Official Journal of the European Society of Mastology·Rita De SanctisArmando Santoro
May 13, 2021·Journal of Complementary & Integrative Medicine·Olorunfemi R MolehinOluwatumininu O Adesua
Apr 29, 2021·Angewandte Chemie·Lorena Simón-GraciaTambet Teesalu
Jul 22, 2021·APL Bioengineering·Chase P MoncktonSalman R Khetani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.